Omeros Financials
3O8 Stock | EUR 7.18 0.09 1.24% |
Omeros |
Understanding current and past Omeros Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Omeros' financial statements are interrelated, with each one affecting the others. For example, an increase in Omeros' assets may result in an increase in income on the income statement.
Omeros Stock Summary
Omeros competes with UNIVMUSIC GRPADR/050, Iridium Communications, PKSHA TECHNOLOGY, Eidesvik Offshore, and United Internet. Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system , and immune-related diseases. The company was incorporated in 1994 and is based in Seattle, Washington. OMEROS CORP operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 236 people.Instrument | Germany Stock View All |
Exchange | Frankfurt Exchange |
ISIN | US6821431029 |
Business Address | The Omeros Building, |
Sector | Healthcare |
Industry | Biotechnology |
Benchmark | Dow Jones Industrial |
Website | www.omeros.com |
Phone | 206 676 5000 |
Currency | EUR - Euro |
You should never invest in Omeros without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Omeros Stock, because this is throwing your money away. Analyzing the key information contained in Omeros' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Omeros Key Financial Ratios
There are many critical financial ratios that Omeros' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Omeros reports annually and quarterly.Return On Asset | -0.36 | |||
Target Price | 34.63 | |||
Number Of Employees | 213 | |||
Beta | 1.18 |
Omeros Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Omeros's current stock value. Our valuation model uses many indicators to compare Omeros value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Omeros competition to find correlations between indicators driving Omeros's intrinsic value. More Info.Omeros is number one stock in return on asset category among its peers. It also is number one stock in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Omeros' earnings, one of the primary drivers of an investment's value.Omeros Systematic Risk
Omeros' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Omeros volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Omeros correlated with the market. If Beta is less than 0 Omeros generally moves in the opposite direction as compared to the market. If Omeros Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Omeros is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Omeros is generally in the same direction as the market. If Beta > 1 Omeros moves generally in the same direction as, but more than the movement of the benchmark.
Omeros March 14, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Omeros help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Omeros. We use our internally-developed statistical techniques to arrive at the intrinsic value of Omeros based on widely used predictive technical indicators. In general, we focus on analyzing Omeros Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Omeros's daily price indicators and compare them against related drivers.
Information Ratio | (0.03) | |||
Maximum Drawdown | 55.68 | |||
Value At Risk | (9.31) | |||
Potential Upside | 8.25 |
Complementary Tools for Omeros Stock analysis
When running Omeros' price analysis, check to measure Omeros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omeros is operating at the current time. Most of Omeros' value examination focuses on studying past and present price action to predict the probability of Omeros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omeros' price. Additionally, you may evaluate how the addition of Omeros to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |